We have located links that may give you full text access.
Hydrophobic and Luminescent Polydimethylsiloxane PDMS-Y 2 O 3 :Eu 3+ Coating for Power Enhancement and UV Protection of Si Solar Cells.
Nanomaterials 2024 April 13
Solar cells have been developed as a highly efficient source of alternative energy, collecting photons from sunlight and turning them into electricity. On the other hand, ultraviolet (UV) radiation has a substantial impact on solar cells by damaging their active layers and, as a result, lowering their efficiency. Potential solutions include the blocking of UV light (which can reduce the power output of solar cells) or converting UV photons into visible light using down-conversion optical materials. In this work, we propose a novel hydrophobic coating based on a polydimethylsiloxane (PDMS) layer with embedded red emitting Y2 O3 :Eu3+ (quantum yield = 78.3%) particles for UV radiation screening and conversion purposes. The favorable features of the PDMS-Y2 O3 :Eu3+ coating were examined using commercially available polycrystalline silicon solar cells, resulting in a notable increase in the power conversion efficiency (PCE) by ~9.23%. The chemical and UV stability of the developed coatings were assessed by exposing them to various chemical conditions and UV irradiation. It was found that the developed coating can endure tough environmental conditions, making it potentially useful as a UV-protective, water-repellent, and efficiency-enhancing coating for solar cells.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app